Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Dec;24(6):743–746. doi: 10.1111/j.1365-2125.1987.tb03240.x

Treatment of bronchial asthma with terfenadine; a randomized controlled trial.

A Taytard 1, D Beaumont 1, J C Pujet 1, M Sapene 1, P J Lewis 1
PMCID: PMC1386398  PMID: 3125852

Abstract

1. Terfenadine, a histamine H1-receptor antagonist, was studied in 52 patients with stable mild perennial asthma with an allergic basis. 2. After a placebo run-in period, patients were randomly allocated to either terfenadine 120 mg twice daily or placebo. After 2 weeks they were crossed over to the other treatment. Forty-six patients completed the study. 3. Terfenadine was significantly more effective than placebo as measured by peak expiratory flows and by symptom scores. 4. These results suggest that histamine may play a more significant role in asthmatic bronchoconstriction than is currently recognised.

Full text

PDF
743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandon M. L., Weiner M. Clinical investigation of terfenadine, a non-sedating antihistamine. Ann Allergy. 1980 Feb;44(2):71–75. [PubMed] [Google Scholar]
  2. Chan T. B., Shelton D. M., Eiser N. M. Effect of an oral H1-receptor antagonist, terfenadine, on antigen-induced asthma. Br J Dis Chest. 1986 Oct;80(4):375–384. doi: 10.1016/0007-0971(86)90091-4. [DOI] [PubMed] [Google Scholar]
  3. Eiser N. M., Mills J., Snashall P. D., Guz A. The role of histamine receptors in asthma. Clin Sci (Lond) 1981 Apr;60(4):363–370. doi: 10.1042/cs0600363. [DOI] [PubMed] [Google Scholar]
  4. Hartley J. P., Nogrady S. G. Effect of an inhaled antihistamine on exercise-induced asthma. Thorax. 1980 Sep;35(9):675–679. doi: 10.1136/thx.35.9.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Karlin J. M. The use of antihistamines in asthma. Ann Allergy. 1972 Jun;30(6):342–347. [PubMed] [Google Scholar]
  7. Kay A. B. Mast cells and their mediators in the pathogenesis of asthma. Eur J Respir Dis Suppl. 1983;128(Pt 1):50–52. [PubMed] [Google Scholar]
  8. Krause L. B., Shuster S. The effect of terfenadine on dermographic wealing. Br J Dermatol. 1984 Jan;110(1):73–79. doi: 10.1111/j.1365-2133.1984.tb07315.x. [DOI] [PubMed] [Google Scholar]
  9. Leeson G. A., Chan K. Y., Knapp W. C., Biedenbach S. A., Wright G. J., Okerholm R. A. Metabolic disposition of terfenadine in laboratory animals. Arzneimittelforschung. 1982;32(9A):1173–1178. [PubMed] [Google Scholar]
  10. Moser L., Hüther K. J., Koch-Weser J., Lundt P. V. Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings. Eur J Clin Pharmacol. 1978 Dec 18;14(6):417–423. doi: 10.1007/BF00716383. [DOI] [PubMed] [Google Scholar]
  11. Nathan R. A., Segall N., Glover G. C., Schocket A. L. The effects of H1 and H2 antihistamines on histamine inhalation challenges in asthmatic patients. Am Rev Respir Dis. 1979 Dec;120(6):1251–1258. doi: 10.1164/arrd.1979.120.6.1251. [DOI] [PubMed] [Google Scholar]
  12. Patel K. R. Terfenadine in exercise induced asthma. Br Med J (Clin Res Ed) 1984 May 19;288(6429):1496–1497. doi: 10.1136/bmj.288.6429.1496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Popa V. T. Bronchodilating activity of an H1 blocker, chlorpheniramine. J Allergy Clin Immunol. 1977 Jan;59(1):54–63. doi: 10.1016/0091-6749(77)90177-4. [DOI] [PubMed] [Google Scholar]
  14. Rafferty P., Holgate S. T. Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways. Am Rev Respir Dis. 1987 Jan;135(1):181–184. doi: 10.1164/arrd.1987.135.1.181. [DOI] [PubMed] [Google Scholar]
  15. Schachter E. N., Brown S., Lach E., Gerstenhaber B. Histamine blocking agents in healthy and asthmatic subjects. Chest. 1982 Aug;82(2):143–147. doi: 10.1378/chest.82.2.143. [DOI] [PubMed] [Google Scholar]
  16. Sorkin E. M., Heel R. C. Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985 Jan;29(1):34–56. doi: 10.2165/00003495-198529010-00002. [DOI] [PubMed] [Google Scholar]
  17. White J., Eiser N. M. The role of histamine and its receptors in the pathogenesis of asthma. Br J Dis Chest. 1983 Jul;77(3):215–226. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES